| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |